-
Why Trxade Health's Stock Is Getting Slammed Today
Tuesday, July 27, 2021 - 9:59am | 175Read More...Trxade Health Inc (NASDAQ: MEDS) shares are trading significantly lower Tuesday after the company announced worse-than-expected Q2 financial results. Trxade Health reported a quarterly earnings loss of 32 cents per share, which was down from a loss of 7 cents per share year-over-year. The...
-
Exclusive: Trxade Group CEO Talks 'Under The Radar' Company On 'Power Hour'
Tuesday, May 4, 2021 - 10:57am | 340Read More...CEO of Trxade Group Inc (NASDAQ: MEDS) Suren Ajjarapu appeared on Benzinga's YouTube show "Power Hour" for an exclusive interview Monday. The pharmaceutical industry total addressable market is expected to reach $685 billion by 2023, Ajjarapu said, adding that the...
